Anogenital Wart Burden and Cost of Illnesses
Measurement of Anogenital Wart Burden, and Cost of Illnesses in Bangkok
1 other identifier
observational
150
1 country
1
Brief Summary
The study will be a prospective study of patients presenting with anogenital warts. The objective are to assess proportion of anogenital warts to the total number of sexual transmitted infection patients, to quantify direct and indirect cost of illnesses and psychological burden associated with anogenital warts and to estimate government program expenditure for the prevention and control and treatment of the STI/anogenital HPV infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 8, 2008
CompletedFirst Posted
Study publicly available on registry
September 9, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedAugust 9, 2010
August 1, 2010
1.2 years
September 8, 2008
August 6, 2010
Conditions
Study Arms (1)
Observation
Eligibility Criteria
Patients presenting with anogenital warts, conducted at Rajavithi General Hospital and Bangrak Hospital
You may qualify if:
- Subject is 18 years of age or older and has anogenital warts
- Physician confirmed clinical diagnosis of anogenital warts
- Subject is capable of understanding the study and the content of the consent form and has agreed to participate in the study by signing the informed consent
- Subject will be available for the study follow up period
You may not qualify if:
- Subject is unable to give informed consent
- Subject has any condition which in the opinion of the investigator might interfere with the evaluation of the study objectives such as other concurrent/active STI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Infectious Diseases Research Unit
Bangkok, Bangkok, 10400, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Prof. Punnee Pitisuttithum, M.B.,B.S.
Mahidol University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 8, 2008
First Posted
September 9, 2008
Study Start
June 1, 2008
Primary Completion
August 1, 2009
Study Completion
August 1, 2009
Last Updated
August 9, 2010
Record last verified: 2010-08